LivaNova today announced its Inspire® innovative adult oxygenator system has treated its one-millionth patient.
Moleculin announced that Dr. Waldemar Priebe, Chair of the Company’s Scientific Advisory Board, has been selected to present at the Global Academic Programs 2018.
VGXI is pleased to announce that Vice President of Operations Dorothy Peterson has been appointed Chief Operating Officer.
Moleculin today announced that it has entered into an agreement to expand production capability for Annamycin.
Bellicum today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock.
Bellicum today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $7.50 per share.
LivaNova announced it received CE Mark for its Vagus Nerve Stimulation Therapy® System comprised of the SenTiva® generator and next-generation Programming System.
Bellicum today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock.